$-2.70
(Market cap
$6 Mln
Revenue (TTM)
$2 Mln
P/E Ratio
--
P/B Ratio
38.4
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-7.3 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
-1.4
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$-3.9
-
Face value
--
-
Shares outstanding
13,649,384
10 Years Aggregate
CFO
$-132.29 Mln
EBITDA
$-180.28 Mln
Net Profit
$-191.50 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
VolitionRX (VNRX)
| -91.5 | -- | -86.1 | -96.9 | -74.1 | -63.4 | -40.2 |
|
BSE Sensex*
| -9.3 | -1.6 | 2.7 | -3.7 | 5.8 | 5.9 | 10.4 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
VolitionRX (VNRX)
| -57.4 | -16.5 | -70.4 | -22.6 | -19.3 | -17.9 | 161.9 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
VolitionRX (VNRX)
|
0.4 | 5.7 | 2.5 | -25.6 | -646.7 | -- | -- | 38.4 |
| 82.4 | 11,993.9 | 669.5 | -320.0 | -0.8 | -71.1 | -- | 26.9 | |
| 263.0 | 16,261.1 | 1,054.4 | 755.9 | 5.7 | -- | 19 | 9.8 | |
| 70.9 | 10,022.2 | 71.0 | -894.0 | -1,175.8 | -- | -- | 60.3 | |
| 54.6 | 13,491.7 | 2,435.9 | 860.6 | 31.0 | 43 | 17.4 | 7.4 | |
| 106.5 | 11,957.0 | 1,663.7 | 413.6 | 36.3 | 430 | 30.9 | 84.5 | |
| 359.4 | 10,402.8 | 440.5 | 241.5 | 33.4 | 18.7 | 44.1 | 7.8 | |
| 540.0 | 12,332.1 | 1,283.9 | -325.1 | -19.0 | -57.7 | -- | 24.0 | |
| 594.0 | 16,765.1 | 2,782.3 | 491.5 | 21.1 | 110.1 | 35.2 | 39.3 | |
| 350.3 | 9,625.4 | 0.0 | -339.1 | -- | -30.6 | -- | 7.6 |
Shareholding Pattern
View DetailsAbout VolitionRX (VNRX)
VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu.Q Vet, a cancer screening... test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis, such as sepsis; Nu.Q Discover, a solution to profiling nucleosomes. It also provides Nu.Q Cancer for predicting treatment response, monitoring treatment response and disease progression, and amending a patient's cancer treatment regimen; and Capture-PCR and Capture-Seq, which are isolating and capturing circulating tumor-derived DNA from plasma samples for early cancer detection. VolitionRx Limited is headquartered in Henderson, Nevada. Read more
-
Executive Chairman
Dr. Martin Charles Faulkes Ph.D.
-
Founder, CEO, President & Director
Mr. Cameron Reynolds MBA
-
Headquarters
Henderson, NV
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for VolitionRX (VNRX)
What is the current share price of VolitionRX Limited (VNRX) Today?
The share price of VolitionRX Limited (VNRX) is $0.43 (NYSE) as of 31-Aug-2026 16:28 EDT. VolitionRX Limited (VNRX) has given a return of -74.11% in the last 3 years.
What is the current PB & PE ratio of VolitionRX Limited (VNRX)?
Since, TTM earnings of VolitionRX Limited (VNRX) is negative, P/E ratio is not available.
The P/B ratio of VolitionRX Limited (VNRX) is 38.44 times as on 21-Aug-2026, a 642 premium to its peers’ median range of 5.18 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-0.06 |
-0.04 |
2024 |
-0.10 |
-0.10 |
2023 |
-0.08 |
-0.37 |
2022 |
-0.23 |
-2.73 |
2021 |
-0.31 |
0.47 |
What is the 52 Week High and Low of VolitionRX Limited (VNRX)?
The 52-week high and low of VolitionRX Limited (VNRX) are Rs 14.70 and Rs 0.38 as of 01-Sep-2026.
What is the market cap of VolitionRX Limited (VNRX)?
VolitionRX Limited (VNRX) has a market capitalisation of $ 6 Mln as on 21-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in VolitionRX Limited (VNRX)?
Before investing in VolitionRX Limited (VNRX), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.